| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 48.63M | 56.95M | 72.29M | 115.52M | 108.69M | 108.54M |
| Gross Profit | -6.66M | -17.25M | 841.00K | 26.03M | 22.83M | 16.51M |
| EBITDA | -17.36M | -30.93M | -9.78M | 17.81M | 14.68M | 6.25M |
| Net Income | -36.28M | -40.98M | -15.48M | 7.50M | 4.39M | 4.19M |
Balance Sheet | ||||||
| Total Assets | 176.92M | 173.97M | 226.05M | 205.85M | 222.86M | 209.57M |
| Cash, Cash Equivalents and Short-Term Investments | 8.50M | 10.94M | 31.16M | 11.68M | 15.14M | 12.69M |
| Total Debt | 29.10M | 31.28M | 39.83M | 31.97M | 21.05M | 8.62M |
| Total Liabilities | 72.51M | 68.22M | 77.56M | 72.93M | 87.87M | 76.36M |
| Stockholders Equity | 104.41M | 105.75M | 148.49M | 132.92M | 134.99M | 133.21M |
Cash Flow | ||||||
| Free Cash Flow | -12.48M | -8.85M | -15.36M | 738.00K | -274.00K | -10.96M |
| Operating Cash Flow | -8.56M | -3.14M | -6.09M | 4.27M | 6.28M | 22.00M |
| Investing Cash Flow | -9.34M | -11.13M | -15.03M | -5.96M | -15.67M | -42.91M |
| Financing Cash Flow | 7.06M | -3.87M | 38.44M | -1.32M | 12.38M | 16.38M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | HK$735.15M | 4.62 | 6.32% | 5.81% | 16.92% | 146.69% | |
68 Neutral | HK$221.28M | 5.01 | 4.73% | ― | -20.52% | -68.47% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | HK$267.95M | 0.98 | 19.13% | ― | -13.26% | 63.38% | |
49 Neutral | HK$1.08B | -2.42 | -15.58% | ― | -8.38% | -86.16% | |
45 Neutral | HK$174.00M | -0.25 | -296.26% | ― | -49.77% | -1095.34% | |
40 Underperform | HK$179.55M | -0.46 | -30.61% | ― | -20.20% | -33.73% |
Sanergy Group Limited has announced that, effective 29 December 2025, it will relocate its principal place of business in Hong Kong to Room 1308, 13/F, China Resources Building, 26 Harbour Road, Wan Chai, reflecting an administrative shift in its local operational base. The company also reported a change in its authorised representative under the Hong Kong Companies Ordinance, with Mr. Lau Che Yan Kenneth resigning from the role effective 2 January 2026 and company secretary Mr. Lam Lok Fung assuming responsibilities for accepting service of process and legal notices in Hong Kong, ensuring continuity in regulatory compliance and corporate governance arrangements.
The most recent analyst rating on (HK:2459) stock is a Sell with a HK$0.11 price target. To see the full list of analyst forecasts on Sanergy Group Ltd. stock, see the HK:2459 Stock Forecast page.
Sanergy Group Limited has announced a further change in the allocation of net proceeds from its Hong Kong listing, revisiting how the remaining HK$45.5 million of the original HK$186.7 million raised will be used. As at 30 June 2025, HK$141.2 million had already been deployed, mainly to pay for the Taigu Assets, working capital, operational costs of the graphite electrode business, and initial upgrades to production systems, with the balance earmarked primarily for upgrading production at its Italian and PRC factories and the Sanli Assets, as well as for expanding its graphite anode materials business. The updated plans confirm that HK$42.2 million is scheduled to be invested in production system upgrades by the second half of 2026 and HK$3.3 million in the graphite anode materials segment by the first half of 2026, signalling continued emphasis on capacity enhancement and diversification within its graphite-related portfolio, which could strengthen operational efficiency and support long‑term growth in its target markets.
The most recent analyst rating on (HK:2459) stock is a Sell with a HK$0.11 price target. To see the full list of analyst forecasts on Sanergy Group Ltd. stock, see the HK:2459 Stock Forecast page.
Sanergy Group Limited, a company incorporated in the Cayman Islands, has issued a supplemental announcement regarding its annual report for the year ended 31 December 2024. The announcement provides additional details about the company’s Share Option Scheme, specifically the exercise period for options, which can be exercised at any time within a period determined by the Board, not exceeding 10 years from the grant date. This supplementary information does not affect other details in the annual report.